Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody Persistence After Recombinant Pertussis Booster in Adults and Elderly
TCTR20250525008Completed
- Sponsor
- Chulalongkorn University
- Start
- Mar 2022
- Countries
- 1
01
Overview
Single-arm trial in pertussis, sponsored by Chulalongkorn University. Started Mar 2022; status: completed.
02
Conditions
pertussis
Beyond the preview
Go deeper on TCTR20250525008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250525008.